Two Weeks of “COVID-19” Search on PubMed.gov
Keywords:
search, PubMed.gov, COVID-19Abstract
Background and aim: Letter to Editor, report the amount of literature generated over two weeks on PubMed.gov related to COVID-19
Methods: reporting the daily number of “hits” from “COVID-19” search on PubMed.gov
Results: There were 66988 entries on PubMed.gov on the search word “COVID-19” on October 24, 2020. The average daily increase in number of entries was 335.
Conclusions: point out the fact that the literature volume is increasing in an exponential manner (www.actabiomedica.it)
References
Chan J, Oo S, Chor C, et al. COVID-19 and literature evidence: should we publish anything and everything? Acta Biomed. 2020 Sep 7;91(3):e2020020. doi: 10.23750/abm.v91i3.9827.
Liu A. Letter to the Editor: Exponential increase in COVID-19 related publications compared to other pandemic diseases. Rambam Maimonides Med J. 2020 Oct 30. doi: 10.5041/RMMJ.10424.
Gianola S, Jesus T, Bargeri S, et al. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic. PLoS ONE. 2020 Oct 6;15(10):e0240123. doi: 10.1371/journal.pone.0240123.
Duong L, Xu P, Liu A. Meningoencephalitis without respiratory failure in a young female patient with COVID-19 infection in Downtown Los Angeles, early April 2020. Brain Behav Immun. 2020 Jul;87:33. doi: 10.1016/j.bbi.2020.04.024
Downloads
Published
Issue
Section
License
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.